The most common side effects are nausea, mild constipation, and reduced appetite, especially in the first 4 to 8 weeks and after each dose increase
The broader enforcement focus: Botox-type products, ophthalmics, clinical trials, recalls The RAPS article also highlights other key enforcement priorities for CDER in 2025: The agency issued 18 warning letters to firms marketing fraudulent or unapproved Botox-type products, warning that such products pose serious safety risks, including potential counterfeiting, incorrect/inactive ingredients, or falsification
TIGIT and PD-1 dual checkpoint blockade enhances antitumor immunity and survival in GBM
Direct RA outcome data is growing, and it was one of the two medications used in the UCLA RA study
doi: 10.1016/j.ejmech.2024.116462
Frequently, it occurs in patients requiring long-term blood transfusion for anemia unrelated to iron deficiency